Abivax

Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.

Filings

4 filings

All Threshold crossing47 Inside information40 Voting rights and capital19 Quarterly financial information5 Earnings release5 Half-year financial report4 Universal registration document2 AGM documents1

08/09/2025
Rapport CAC sur l'information semestrielle 2025
Half-year financial reportFrench
08/09/2025
Lettre d'affirmation sur les comptes semestriels 2025
Half-year financial reportFrench
08/09/2025
Rapport financier semestriel 2025
Half-year financial reportFrench
08/09/2025
Déclaration de la personne responsable RFS - Abivax
Half-year financial reportFrench

About

ISIN: FR0012333284
Ticker: ABVX
LEI: 969500D8TMNB184OJU95
Sector: Health care
Country of registration: FR
Last filing: 30/07/2026, 22:05

Wikipedia

Description from Wikidata, CC0 licence.

Filing history

Filings per month

Sept 23May 24Jan 25Sept 25Aug 26

Document types

Across the whole archive